trans-Oct-2-enoyl-CoA (BioCAD00000018718)
{$topic}
Metabolite Card
Formula: C29H48N7O17P3S (891.204)
SMILES: CCCCC\C=C\C(=O)SCCNC(=O)CCNC(=O)C(O)C(C)(C)COP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(O)(O)=O)N1C=NC2=C1N=CN=C2N
Synonyms [en]
trans-Oct-2-enoyl-CoA; 2E-octenoyl-CoA; (2E)-Octenoyl-CoA; oct-2-trans-enoyl-CoA; 2,3-trans-octenoyl coenzyme A; trans-oct-2-enoyl-coenzyme A
Last reviewed on 2024-06-28.
Cite this Page
trans-Oct-2-enoyl-CoA. 数据之源,洞见之始. SMRUCC genomics institute, a synthetic life researcher from China.
https://biocad_registry.innovation.ac.cn/s/(-)-arctiin
(retrieved
2026-01-03) (CAD Registry RN: BioCAD00000018718). Licensed
under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0).
Note
(2E)-Octenoyl-CoA is the main metabolite produced in medium-chain acyl-CoA dehydrogenase (EC 1.3.99.3, MCAD) deficiency; however the product of the enzymatic reaction is not directly detected in several methods for screening of inborn errors of fatty acid oxidation. In order to aid the timely follow-up of screening results that suggest abnormalities in MCAD, rapid and simple confirmatory tests for the enzyme activity and/or gene mutation analysis should be available. Medium-chain fatty acyl-CoA dehydrogenase (MCAD) catalyzes the conversion of different chain length fatty acyl- CoAs into their corresponding trans-enoyl-CoA moieties via two consecutive sequences of steps. The first step involves the concerted abstraction of a proton and a hydride ion from the a- and 8-carbon chains of the fatty acyl-CoA substrates, concomitant with the reduction of the enzyme (E)-bound FAD to FADH2. The reoxidation of EFADH2, to propagate further rounds of catalysis, is accomplished via transfer of electrons to a variety of organic electron acceptors; the natural electron acceptor for this process, under physiological conditions, is the electron-transferring flavoprotein. Of the different chain length fatty acyl-CoA substrates, octanoyl-CoA/octenoyl-CoA have been known as the most efficient (and physiological) substrates for the medium-chain fatty acyl-CoA dehydrogenase (MCAD)-catalyzed reaction. (PMID: 16046200, 1390638, 8038175).
DBLinks
- CAS Registry Number: 10018-94-7
- PubChem CID: 5280769
- ChEBI: 27537
- HMDB: HMDB0003949
- LipidMaps: LMFA07050394
- KEGG: C05276
- BioCyc: CPD0-2108
- NCBI MeSH: octenoyl-coenzyme A
- Wikipedia:
Other DBLinks
- CAS Registry Number: 10018-94-7
- PubChem: 11966175
- PubChem: 5280769
- ChEBI: ChEBI:27537
- HMDB: HMDB0003949
- HMDB: HMDB02992
- LipidMaps: LMFA07050024
- LipidMaps: LMFA07050394
- KEGG: C05276
- BioCyc: CPD0-2108
- NCBI MeSH: octenoyl-coenzyme A
- RefMet: RM0136864
- Metlin: METLIN_36656
- Coconut NaturalProduct: CNP0083557.1
Class / Ontology
- WishartLab ClassyFire: [Fatty acyl thioesters] Fatty acyl thioesters
- RefMet: [Acyl CoAs] Acyl CoAs
- LipidMaps: [Fatty acyl CoAs [FA0705]] Fatty acyl CoAs [FA0705]
- ChEBI: [CHEBI:27537] trans-oct-2-enoyl-CoA
- Coconut NaturalProduct: [Fatty acyl CoAs] Fatty acyl CoAs
| ID | EC Number | Name |
|---|---|---|
| KEGG:R03776 | 1.3.1.8 | trans-Oct-2-enoyl-CoA reductase |
| KEGG:R03777 | 1.3.3.6 | octanoyl-CoA:electron-transfer flavoprotein 2-oxidoreductase |
| KEGG:R04746 | 4.2.1.17 | (S)-hydroxyoctanoyl-CoA hydro-lyase |
| BioCyc:RXN-20678 | 4.2.1.74 | CPD-22313<=>CPD0-2108 + WATER |
| BioCyc:RXN-14229 | 1.3.8.7 | CPD-196 + ETF-Oxidized + PROTON --> CPD0-2108 + ETF-Reduced |
| BioCyc:RXN-12669 | 1.3.3.6 | CPD-196 + OXYGEN-MOLECULE --> CPD0-2108 + HYDROGEN-PEROXIDE |
| BioCyc:RXN-14276 | 4.2.1.119 | CPD0-2108 + WATER --> CPD-14916 |
| BioCyc:RXN-19515 | 2.3.1.- | CPD-1022 + CPD0-2108 --> CPD-21027 + CO-A |
| BioCyc:RXN-18752 | 5.3.3.8 | CPD-14729<=>CPD0-2108 |
Taxonomy Source
Pathway Synthetic
| pathway id | name |
|---|---|
| PathBank:SMP0001038 | fatty acid oxidation (octanoate) |
| WikiPathways:WP1307 | Fatty acid beta-oxidation |
| PathBank:SMP0120822 | Carnitine Palmitoyl Transferase Deficiency I |
| PathBank:SMP0120826 | Medium Chain Acyl-CoA Dehydrogenase Deficiency (MCAD) |
| PathBank:SMP0120476 | Ethylmalonic Encephalopathy |
| PathBank:SMP0120520 | Short-Chain Acyl-CoA Dehydrogenase Deficiency (SCAD Deficiency) |
| PathBank:SMP0120605 | Very-Long-Chain Acyl-CoA Dehydrogenase Deficiency (VLCAD) |
| PathBank:SMP0120609 | Trifunctional Protein Deficiency |
| PathBank:SMP0000051 | Fatty Acid Metabolism |
| PathBank:SMP0000235 | Short-Chain Acyl-CoA Dehydrogenase Deficiency (SCAD Deficiency) |
| PathBank:SMP0000540 | Very-Long-Chain Acyl-CoA Dehydrogenase Deficiency (VLCAD) |
| PathBank:SMP0000544 | Long-Chain-3-Hydroxyacyl-CoA Dehydrogenase Deficiency (LCHAD) |
| PathBank:SMP0087266 | Mitochondrial Beta-Oxidation of Medium Chain Saturated Fatty Acids |
| PathBank:SMP0087294 | Fatty Acid Elongation in Mitochondria |
| PathBank:SMP0087430 | Fatty Acid Metabolism |
| PathBank:SMP0063612 | Fatty Acid Elongation In Mitochondria |
| PathBank:SMP0120825 | Carnitine Palmitoyl Transferase Deficiency II |
| PathBank:SMP0120604 | Long Chain Acyl-CoA Dehydrogenase Deficiency (LCAD) |
| PathBank:SMP0120608 | Long-Chain-3-Hydroxyacyl-CoA Dehydrogenase Deficiency (LCHAD) |
| PathBank:SMP0121069 | Fatty Acid Elongation |